Enanta Pharmaceuticals Inc Sustainability Reports
Enanta Pharmaceuticals, Inc. is a clinical-stage biotechnology company that discovers and develops oral small molecule drugs. The company focuses primarily on treating diseases and infections within the fields of virology and immunology.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900SSN4DODDQSN594
FIGI: BBG001V9NSC3
11 reports from 2015 to 2025
